J Clin Psychopharmacol

• 

  Publication Venue For

  • Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series..  38:149-150. 2018
  • Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders..  37:684-688. 2017
  • The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia..  37:651-656. 2017
  • Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms..  35:374-381. 2015
  • High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study..  33:485-490. 2013
  • The association of dehydroepiandrosterone and dehydroepiandrosterone sulfate with anxiety sensitivity and electronic diary negative affect among smokers with and without posttraumatic stress disorder..  33:556-560. 2013
  • Comparison of academic and nonacademic sites in multi-center clinical trials..  32:65-68. 2012
  • Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder..  31:727-733. 2011
  • A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients..  31:532-534. 2011
  • Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly..  31:544-546. 2011
  • Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy..  31:207-213. 2011
  • Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication..  31:180-186. 2011
  • The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study..  31:31-38. 2011
  • Reduced cannabis use after low-dose naltrexone addition to opioid detoxification..  30:476-478. 2010
  • Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report..  30:259-266. 2010
  • Expanded studies of the pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers..  29:426-431. 2009
  • Toxic interaction between valproate and oxcarbazepine: a case detected by the free valproate level..  28:472-473. 2008
  • Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder. 2014